Charles van Es - 10 Mar 2023 Form 4 Insider Report for Vita Coco Company, Inc. (COCO)

Role
Chief Sales Officer
Signature
By: Yolanda Goettsch, Attorney-in-Fact For: Charles Van Es
Issuer symbol
COCO
Transactions as of
10 Mar 2023
Net transactions value
$0
Form type
4
Filing time
14 Mar 2023, 21:36:40 UTC
Previous filing
01 Dec 2022
Next filing
18 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COCO Common Stock Award $0 +5,914 +6.8% $0.000000 93,258 10 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COCO Non-Qualified Stock Option (right to buy) Award $0 +14,205 $0.000000 14,205 10 Mar 2023 Common Stock 14,205 $16.91 Direct F2
holding COCO Non-Qualified Stock Option (right to buy) 129,675 10 Mar 2023 Common Stock 129,675 $10.18 Direct F3
holding COCO Non-Qualified Stock Option (right to buy) 113,750 10 Mar 2023 Common Stock 113,750 $10.18 Direct F4
holding COCO Non-Qualified Stock Option (right to buy) 27,300 10 Mar 2023 Common Stock 27,300 $10.18 Direct F5
holding COCO Non-Qualified Stock Option (right to buy) 58,043 10 Mar 2023 Common Stock 58,043 $15.00 Direct F6
holding COCO Non-Qualified Stock Option (right to buy) 42,980 10 Mar 2023 Common Stock 42,980 $15.36 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.
F2 The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
F3 The stock option is fully vested and currently exercisable.
F4 The stock option is fully vested and currently exercisable with respect to 56,875 underlying shares. The remainder will vest on February 10, 2024.
F5 The stock option vests in two equal installments on January 11, 2023 and January 11, 2025.
F6 The stock option vests in four equal annual installments beginning on November 27, 2022.
F7 The stock option vests in three equal annual installments beginning on August 15, 2025.